Synovial Sarcoma Chromatin Dynamics Reveal a Continuum in SS18:SSX Reprograming
Hofvander, J.; Qiu, A.; Lee, K.; Bilenky, M.; Carles, A.; Cao, Q.; Moksa, M.; Steif, J.; Su, E.; Sotiriou, A.; Goytain, A.; Hill, L.; Singer, S.; Andulis, I.; Wunder, J.; Mertens, F.; Banito, A.; Jones, K. B.; Underhill, T. M.; Nielsen, T.; Hirst, M.
Show abstract
Synovial sarcoma (SyS) is an aggressive soft-tissue malignancy characterized by a pathognomonic chromosomal translocation leading to the formation of the SS18::SSX fusion oncoprotein. SS18::SSX associates with mammalian BAF complexes suggesting deregulation of chromatin architecture as the oncogenic driver in this tumour type. To examine the epigenomic state of SyS we performed comprehensive multi-omics analysis on 52 primary pre-treatment human SyS tumours. Our analysis revealed a continuum of epigenomic states across the cohort at fusion target genes independent of rare somatic genetic lesions. We identify cell-of-origin signatures defined by enhancer states and reveal unexpected relationships between H2AK119Ub1 and active marks. The number of bivalent promoters, dually marked by the repressive H3K27me3 and activating H3K4me3 marks, has strong prognostic value and outperforms tumor grade in predicting patient outcome. Finally, we identify SyS defining epigenomic features including H3K4me3 expansion associated with striking promoter DNA hypomethylation in which SyS displays the lowest mean methylation level of any sarcoma subtype. We explore these distinctive features as potential vulnerabilities in SyS and identify H3K4me3 inhibition as a promising therapeutic strategy.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A single cell atlas reveals distinct immune landscapes in transplant and primary tumors that determine response or resistance to immunotherapy 96%
- Single-cell multi-omic analysis of the vestibular schwannoma ecosystem uncovers a nerve injury-like state 96%
- EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition 95%
Similar papers in this journal
- YAP1 is a key regulator of EWS::FLI1-dependent malignant transformation upon IGF-1 mediated reprogramming of bone mesenchymal stem cells 95%
- Epigenomic signatures as circulating and predictive biomarkers in sarcomatoid renal cell carcinoma 95%
- Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors 95%
Similar papers in this journal
- PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcoma 95%
- Acquired RAD51C promoter methylation loss causes PARP inhibitor resistance in high grade serous ovarian carcinoma 94%
- EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes 94%
Similar papers in this journal
- Multiscale 3D Genome Reorganization during Skeletal Muscle Stem Cell Lineage Progression and Muscle Aging 94%
- Mutational processes of tobacco smoking and APOBEC activity generate protein-truncating mutations in cancer genomes 93%
- Charting the transcriptomic landscape of primary and metastatic cancers in relation to their origin and target normal tissues 93%
Similar papers in this journal
- Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome 95%
- Cell cycle alterations associate with a redistribution of mutation rates across chromosomal domains in human cancers 95%
- Cell lineage as a predictor of immune response in neuroblastoma 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.